TrialMultiple sclerosis and related disorders2016

Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials.

Tobias Derfuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.